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Introduction: The pituitary gland is an uncommon site for metastases, in particular from rhabdomyosarcoma.
Some authors have reported a recent increase in the incidence of metastases at infrequent sites, such as brain
or bone, probably due to the expanded treatment options and the resulting improved survival. Treatment options
are limited, but must be discussed and adapted to the patient profile.
Case presentation: We report the case of a 17-year-old Arabic man, diagnosed with alveolar rhabdomyosarcoma of
the left shoulder, who, after several cycles of chemotherapy, presented symptoms and signs of pituitary dysfunction.
To the best of our knowledge, it is the first case described.
Conclusions: Pituitary metastasis of rhabdomyosarcoma is a rare situation, which must be actively researched to have
access to an optimal therapeutic approach.
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The occurrence of pituitary metastasis is a very rare com-
plication in oncology [1]. Data from many autopsy series
state that pituitary metastases occur in 1 to 3.6 percent of
patients with advanced tumors [2]. Tumors responsible
for this type of extension are, in descending order: breast,
lung, prostate, kidney and those of the gastrointestinal
tract [3]. Some cases of lymphoma and plasmacytoma
have been described in the literature [2,3]. Alveolar
rhabdomyosarcoma is an aggressive tumor, with rapid and
unpredictable evolutionary potential. Treatment options
are limited, and the prognosis very poor [4]. We report in
this manuscript the first case of metastasis of rhabdomyo-
sarcoma to the pituitary gland.
Case presentation
A 17-year-old Arabic man was admitted to our medical
oncology department for management of alveolar
rhabdomyosarcoma (RMS) of the left shoulder. The ini-
tial workup included a computed tomography (CT) scan
of the body and a bone scan, which revealed lung and
bone metastases. Chemotherapy with an IVA regimen
was initiated (ifosfamide 5g/m2 intravenously, day 1;* Correspondence: ismail_onco@yahoo.fr
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unless otherwise stated.vincristine 2mg intravenously, day 1; doxorubicin 50mg/m2
intravenously, day 1; and zoledronic acid 4mg intravenously
repeated every 21 days). His radiological and clinical evalu-
ation after three courses of treatment showed a stable dis-
ease, with significant improvement in quality of life. After
his fifth cycle of chemotherapy, he presented to our emer-
gency department with polydipsia and polyuria, headache
and vomiting associated to diplopia, and a decrease in
visual acuity in his left eye. A CT scan of his brain revealed
a 13 × 15mm diameter pituitary lesion (Figures 1, 2 and 3).
A transsphenoidal biopsy was performed and a histopatho-
logical examination, as well as molecular diagnostics, con-
firmed the diagnosis of an alveolar rhabdomyosarcoma
(Figure 4). He was treated by whole-brain external beam
radiation therapy, at a dose of 30Gy in 10 fractions of 3Gy,
using 6MV photons of linear accelerator, with spectacular
regression of his neurological symptoms. He received
second-line chemotherapy (gemcitabine 1000mg/m2 and
oxaliplatin 100mg/m2 every two weeks); unfortunately, he
died after two cycles.
Discussion
RMS is the most common soft-tissue tumor of child-
hood, and responsible for approximately one-half of all
soft-tissue sarcomas in this age group [5,6]. However,
they are rare, representing only 3 to 4 percent oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Cross-sectional computed tomography scan showing
a pituitary mass.
Figure 3 Sagittal computed tomography scan showing a
pituitary mass.
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are diagnosed in the US each year, and the annual inci-
dence in children, adolescents, and young adults under
the age of 20 is 4.3 cases per one million population [5].
Lung is the most frequent site of metastases fromFigure 2 Coronal computed tomography scan section showing
a pituitary mass.rhabdomyosarcoma. Other sites of distant metastatic in-
volvement include bone marrow (approximately 30 per-
cent), bone (30 percent); omentum/ascites (16 percent),
and pleura (13 percent); visceral involvement and brain
metastases are rare [7-10]. To the best of our knowledge,
a pituitary metastasis from rhabdomyosarcoma has
never been reported in the literature. In the widest re-
view of literature about pituitary metastases including
380 patients, none of them had a RMS as the primary
localization [11]. These data confirm the authenticity of
our report. The incidence of pituitary metastases on
autopsy is between 1 and 3.6 percent [12,13], and if
the parasellar region is included the incidence rises up
to 27 percent [14]. Breast and lung carcinoma are the
two most common forms of malignant tumor that
metastasize to the pituitary gland. The most common
symptom seems to be diabetes insipidus [15,16], reflect-
ing a predominance of metastasis to the posterior lobe.Figure 4 Monomorphic dense cell proliferation with a high
nucleocytoplasmic ratio (alveolar rhabdomyosarcoma).
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field impairment [17]. Infiltration of the adjacent cavern-
ous sinus usually induces cranial nerve III palsy, or less
frequently, nerve IV palsy. Compression of nerve VI is
relatively uncommon because it is well sheltered within
the cavernous sinus [18]. Facial numbness due to cranial
nerve V dysfunction is also rare [18]. Tumor extension
to the septum pellucidum or the frontal lobes may result
in cognitive deficit or psychiatric symptoms, and in an-
osmia if cranial nerve I is affected [16,18]. Stretching of
the diaphragma sellae or ventricular distention can give
rise to headaches or intracranial hypertension. All these
symptoms, except for diabetes insipidus, are common in
pituitary adenomas. The question is how to differentiate
pituitary metastasis from pituitary adenoma in patients
with a history of malignant disease, but also in those in
which pituitary metastasis is the initial symptom of a
malignant disease. Clinically, the presence of diabetes
insipidus is very suggestive of pituitary metastasis and
can be the first manifestation of a malignant neoplasm
[19]. Although history or coexistence of malignancy usu-
ally leads to the diagnosis, it is of limited diagnostic
value because 1.8 to 16 percent of patients with known
malignancy and a sellar tumor turn out to harbor a pitu-
itary adenoma [17,20]. With regard to neuroimaging
findings, sensitive and specific criteria for differentiating
pituitary metastases from pituitary adenomas have not
been reported and radiological evaluation generally has
not been fruitful [21], unless other metastatic brain
lesions coexist. A few imaging characteristics have been
reported to be helpful in differentiating pituitary metas-
tases from pituitary adenomas; these include the follow-
ing: 1) thickening of the pituitary stalk; [17,22] 2) loss
of a high-intensity signal from the posterior pituitary;
[23] 3) isointensity on both T1- and T2-weighted mag-
netic resonance images; [22] 4) invasion of the cavernous
sinus; [22] and 5) sclerotic changes around the sella
turcica [24]. Although these findings may indicate the
possibility of metastases, they are in no way specific for
pituitary metastases [2].
Treatment, mostly palliative, depends on symptoms.
Surgical exploration and decompression, alone or com-
bined with radiation, is often necessary when suprasellar
extension causes progressive deterioration in vision and/
or pain [25]. In our case, whole-brain external beam
radiation therapy allowed improvement in symptoms,
especially headache and visual field defects.
The prognosis is generally poor, because the vast
majority of cases of pituitary metastasis occur in
association with multiple systemic metastases and are
typically associated with end-stage disease. [2]. Mean
survival rates have been reported to be between 6 and
22 months, independent of the treatment strategy
[17,25].Conclusions
Here we report the case of a patient presenting with
metastatic alveolar RMS, with a large sellar mass having
appeared under treatment. This metastatic event is very
uncommon, making it almost impossible to perform
prospective clinical trials specifically designed to com-
pare different treatment approaches. Thus, only a greater
awareness of the problem along with a more accurate
and timely diagnosis, will lead to choosing the best
therapies suitable to the specific patient and, in turn,
improve overall prognosis.
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